These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6138177)

  • 1. Nonselective beta-receptor stimulation and blockade and left ventricular function.
    Leenen FH; Smith DL; DeLeve L
    Clin Pharmacol Ther; 1983 Nov; 34(5):570-5. PubMed ID: 6138177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-receptor-mediated increase in venous return in humans.
    Leenen FH; Reeves RA
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1658-65. PubMed ID: 2825941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epinephrine and left ventricular function in humans: effects of beta-1 vs nonselective beta-blockade.
    Leenen FH; Chan YK; Smith DL; Reeves RA
    Clin Pharmacol Ther; 1988 May; 43(5):519-28. PubMed ID: 2896556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
    Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of cardiac and renal beta-receptors by low dose propranolol in normal subjects. Clues to its antihypertensive effect.
    Davies R; Pickering TG; Morganti A; Wilson M; Laragh JH
    Br Heart J; 1979 Mar; 41(3):331-5. PubMed ID: 34409
    [No Abstract]   [Full Text] [Related]  

  • 6. Reflex vagal withdrawal and the hemodynamic response to intravenous isoproterenol in the presence of beta-antagonists.
    Arnold JM; McDevitt DG
    Clin Pharmacol Ther; 1986 Aug; 40(2):199-208. PubMed ID: 3015474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta blockade by oral propranolol and labetalol.
    Cubeddu LX; Carr ME; Fuenmayor NJ
    Clin Pharmacol Ther; 1985 Mar; 37(3):277-83. PubMed ID: 2857602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG; Shanks RG
    Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration.
    Spotnitz HM; Avery GJ; Rose EA; Benvenisty AI; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):103-8. PubMed ID: 6243164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of cardiac effects of timolol and propranolol.
    Achong MR; Piafsky KM; Ogilvie RI
    Clin Pharmacol Ther; 1976 Feb; 19(2):148-52. PubMed ID: 4254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects.
    Boudoulas H; Lewis RP; Kates RE; Dalamangas G
    Ann Intern Med; 1977 Oct; 87(4):433-6. PubMed ID: 199099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In support of cardiac chronotropic beta 2 adrenoceptors.
    Brown JE; McLeod AA; Shand DG
    Am J Cardiol; 1986 Apr; 57(12):11F-16F. PubMed ID: 3010692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic receptor desensitization in man: insight into post-exercise attenuation of cardiac function.
    Hart E; Dawson E; Rasmussen P; George K; Secher NH; Whyte G; Shave R
    J Physiol; 2006 Dec; 577(Pt 2):717-25. PubMed ID: 16973702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insurmountable beta receptor blockade by ICI 147,798 in rabbits.
    Murthy VS; Hwang TF; Wurm R; Zagar ME; Keith RA; Kau ST; Salama AI; Giles RE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):249-55. PubMed ID: 2563289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for cardiac beta 2-adrenoceptors in man.
    Brown JE; McLeod AA; Shand DG
    Clin Pharmacol Ther; 1983 Apr; 33(4):424-8. PubMed ID: 6299641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
    Schiffelers SL; Blaak EE; Saris WH; van Baak MA
    Clin Pharmacol Ther; 2000 May; 67(5):558-66. PubMed ID: 10824635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure.
    Litwin SE; Katz SE; Morgan JP; Douglas PS
    Br J Pharmacol; 1999 Aug; 127(7):1671-9. PubMed ID: 10455325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cardiac effects of timolol and propranolol.
    Achong MR; Piafsky KM; Ogilvie RI
    Clin Pharmacol Ther; 1975 Sep; 18(3):278-86. PubMed ID: 1100298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
    Perucca E; Pickles H; Richens A
    Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.